The DOI matches its Crossref record.
Changes in bone mass during prolonged subclinical hyperthyroidism due to l-thyroxine treatment: a meta-analysis
Abstract
L-Thyroxine (L-T4) in the treatment of thyroid disease resulting in reduced serum thyrotropin (TSH) has been associated with reduced bone mass and thus the potential risk of premature development of osteoporosis. However, several recent studies have failed to show such a detrimental effect. These disagreements are probably due to only a small number of patients taking part in each study, decreasing the change of finding significant differences and increasing the risk of missing a real difference (type 1 and 2 errors, respectively). We therefore performed a meta-analysis on the available papers (N = 13), in which bone mass was measured in the distal forearm, femoral neck or lumbar spine in a cross-sectional manner in women with suppressed serum TSH due to L-T4 treatment and in a control group. The women were divided according to their pre- and postmenopausal state, because preserved estrogen production plays a protective role against irreversible bone loss. Based on the number of measurements performed on the different sites of the skeleton, a theoretical bone composed of 30.4% distal forearm, 28.8% femoral neck and 40.8% lumbar spine could be constructed in premenopausal women (441 measurements). A premenopausal woman at an average age of 39.6 years and treated with 164 micrograms L-T4/day for 8.5 years, leading to suppressed serum TSH, had 2.67% less bone mass than controls (NS), corresponding to an excess annual bone loss of 0.31% after 8.5 years of treatment (NS). The risk…
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“The results of our meta-analysis reinforce the previous reports that levothyroxine treatment-induced subclinical hyperthyroidism affects BMD reduction in postmenopausal women (16,17,34) for various causes other than DTC were mixed, and the degree of TSH suppression varied considerably.”
From Effect of TSH Suppression Therapy on Bone Mineral Density in Differentiated Thyroid Cancer: A Systematic Review and Meta-analysis (2021) · cites this paper as [17]
In the citing paper
“A previous metaanalysis of 13 cross-sectional studies regarding the effect of induced subclinical hyperthyroidism during long-term levothyroxine treatment on BMD showed no significant differences in premenopausal women, unlike postmenopausal women who displayed significant bone loss compared with the control groups (17).”
From Effect of TSH Suppression Therapy on Bone Mineral Density in Differentiated Thyroid Cancer: A Systematic Review and Meta-analysis (2021) · cites this paper as [17]
Citations
Cites
Still being checked.
Cited by
Sorted by citations
Subclinical Thyroid Disease: Scientific Review and Guidelines for Diagnosis and Management
Surks, M. I., Ortiz, E., Daniels, G. H., Sawin, C. T., Col, N. F., Cobin, R. H., Franklyn, J. A., Hershman, J. M., Burman, K. D., Denke, M. A., et al. (2004) · JAMA · doi:10.1001/jama.291.2.228 · Cited by 1,800
Garber, J. R., Cobin, R. H., Gharib, H., Hennessey, J. V., Klein, I., Mechanick, J. I., Pessah-Pollack, R., Singer, P. A., & Woeber, K. A. (2012) · Endocrine Practice · doi:10.4158/ep12280.gl · Cited by 1,567
Clinical Practice Guidelines for Multiple Endocrine Neoplasia Type 1 (MEN1)
Thakker, R. V., Newey, P. J., Walls, G. V., Bilezikian, J. P., Dralle, H., Ebeling, P. R., Melmed, S. K., Sakurai, A., Tonelli, F., & Brandi, M. L. (2012) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2012-1230 · Cited by 1,500
The Clinical Significance of Subclinical Thyroid Dysfunction
Biondi, B., & Cooper, D. S. (2008) · Endocrine Reviews · doi:10.1210/er.2006-0043 · Cited by 1,418
Gharib, H., Papini, E., Garber, J. R., Duick, D. S., Harrell, R. M., Hegedűs, L. D., Paschke, R., Valcavi, R., & Vitti, P. (2016) · Endocrine Practice · doi:10.4158/ep161208.gl · Cited by 1,285
Management Guidelines for Children with Thyroid Nodules and Differentiated Thyroid Cancer
Francis, G. L., Waguespack, S. G., Bauer, A. J., Angelos, P., Benvenga, S., Cerutti, J. M., Dinauer, C., Hamilton, J. K., HAY, I. D., Luster, M., et al. (2015) · Thyroid · doi:10.1089/thy.2014.0460 · Cited by 1,273
Gharib, H., Papini, E., Paschke, R., Duick, D. S., Valcavi, R., Hegedűs, L. D., Vitti, P., Gharib, H., Papini, E., Paschke, R., et al. (2010) · Endocrine Practice · doi:10.4158/10024.gl · Cited by 1,087
Garber, J. R., Cobin, R. H., Gharib, H., Hennessey, J. V., Klein, I., Mechanick, J. I., Pessah-Pollack, R., Singer, P. A., & Woeber for the American Association, K. A. (2012) · Thyroid · doi:10.1089/thy.2012.0205 · Cited by 1,053
Management of Simple Nodular Goiter: Current Status and Future Perspectives
Hegedűs, L. D., Bonnema, S. J., & Bennedbæk, F. N. (2003) · Endocrine Reviews · doi:10.1210/er.2002-0016 · Cited by 704
Gharib, H., Papini, E., Valcavi, R., Baskin, H. J., Crescenzi, A., Dottorini, M. E., Duick, D. S., Guglielmi, R., Hamilton, C. R., Zeiger, M. A., et al. (2006) · Endocrine Practice · doi:10.4158/ep.12.1.63 · Cited by 680
American Thyroid Association guidelines for detection of thyroid dysfunction.
Ladenson, P., Singer, P., Ain, K., Bagchi, N., Bigos, S., Levy, E., Smith, S. A., Daniels, G., & Cohen, H. D. (2000) · Archives of Internal Medicine · doi:10.1001/archinte.160.11.1573 · Cited by 658
Role of Thyroid Hormones in Skeletal Development and Bone Maintenance
Bassett, J. H. D., & Williams, G. R. (2016) · Endocrine Reviews · doi:10.1210/er.2015-1106 · Cited by 540
Saravanan, P., Chau, W. ‐., Roberts, N., Vedhara, K., Greenwood, R., & Dayan, C. M. (2002) · Clinical Endocrinology · doi:10.1046/j.1365-2265.2002.01654.x · Cited by 514
Effects on bone mass of long term treatment with thyroid hormones: a meta-analysis
Uzzan, B., Campos, J., Cucherat, M., Nony, P., Boissel, J. P., & Perret, G. Y. (1996) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jcem.81.12.8954028 · Cited by 398
Thyroid Nodules: Clinical Importance, Assessment, and Treatment
Gharib, H., & Papini, E. (2007) · Endocrinology and Metabolism Clinics of North America · doi:10.1016/j.ecl.2007.04.009 · Cited by 395
Osteoporosis Due to Cancer Treatment: Pathogenesis and Management
Pfeilschifter, J., & Diel, I. (2000) · Journal of Clinical Oncology · doi:10.1200/jco.2000.18.7.1570 · Cited by 362
Epidemiology and prevention of clinical and subclinical hypothyroidism.
Vanderpump, M. P. J., & Tunbridge, W. M. G. (2002) · Thyroid · doi:10.1089/105072502761016458 · Cited by 347
Publication Bias (The "File-Drawer Problem") in Scientific Inference
Scargle, J. D. (1999) · arXiv · doi:10.48550/arxiv.physics/9909033 · Cited by 313
Secondary Causes of Osteoporosis
FITZPATRICK, L. A. (2002) · Mayo Clinic Proceedings · doi:10.1016/s0025-6196(11)62214-3 · Cited by 311
Helfand, M. (2004) · Annals of Internal Medicine · doi:10.7326/0003-4819-140-2-200401200-00015 · Cited by 302
Casey, B. M., & Leveno, K. J. (2006) · Obstetrics and Gynecology · doi:10.1097/01.aog.0000244103.91597.c5 · Cited by 291
Thyroid diseases and bone health
Williams, G. R., & Bassett, J. H. D. (2018) · Journal of Endocrinological Investigation · doi:10.1007/s40618-017-0753-4 · Cited by 276
Treatment with thyroid hormone
Biondi, B., & Wartofsky, L. (2014) · Endocrine Reviews · doi:10.1210/er.2013-1083 · Cited by 259
Hoogendoorn, E. H., Hermus, A. R., de Vegt, F., Ross, H. A., Verbeek, A. L., Kiemeney, L. A., Swinkels, D. W., Sweep, F. C., & den Heijer, M. (2006) · Clinical Chemistry · doi:10.1373/clinchem.2005.055194 · Cited by 255
Continuing Controversies in the Management of Thyroid Nodules
Castro, M. R., & Gharib, H. (2005) · Annals of Internal Medicine · doi:10.7326/0003-4819-142-11-200506070-00011 · Cited by 256
The Effect of Thyroid Hormone on Skeletal Integrity
Greenspan, S. L., & Greenspan, F. S. (1999) · Annals of Internal Medicine · doi:10.7326/0003-4819-130-9-199905040-00016 · Cited by 249
Thyroid Hormone Diseases and Osteoporosis
Delitala, A. P., Scuteri, A., & Doria, C. (2020) · Journal of Clinical Medicine · doi:10.3390/jcm9041034 · Cited by 220
CHANGING CONCEPTS IN THE DIAGNOSIS AND MANAGEMENT OF THYROID NODULES
Gharib, H. (1997) · Endocrinology and Metabolism Clinics of North America · doi:10.1016/s0889-8529(05)70282-6 · Cited by 218
Subclinical hyperthyroidism: clinical features and treatment options
Biondi, B., Palmieri, E. A., Klain, M., Schlumberger, M., Filetti, S., & Lombardi, G. (2005) · European Journal of Endocrinology · doi:10.1530/eje.1.01809 · Cited by 217
Vanderpump, M. P. J., Ahlquist, J., Franklyn, J., & Clayton, R. (1996) · BMJ · doi:10.1136/bmj.313.7056.539 · Cited by 233
FINE-NEEDLE ASPIRATION BIOPSY OF THE THYROID
Belfiore, A., & Rosa, G. L. L. (2001) · Endocrinology and Metabolism Clinics of North America · doi:10.1016/s0889-8529(05)70191-2 · Cited by 211
Evaluation and Management of the Solid Thyroid Nodule
Burch, H. B. (1995) · Endocrinology and Metabolism Clinics of North America · doi:10.1016/s0889-8529(18)30019-7 · Cited by 208
Controversies in the management of cold, hot, and occult thyroid nodules
Giuffrida, D., & Gharib, H. (1995) · The American Journal of Medicine · doi:10.1016/s0002-9343(99)80252-6 · Cited by 203
Treatment for primary hypothyroidism: current approaches and future possibilities
Vaidya, B., Chakera, A. J., & Pearce, S. H. S. (2011) · Drug Design Development and Therapy · doi:10.2147/dddt.s12894 · Cited by 204
Overt and Subclinical Hypothyroidism
Khandelwal, D., & Tandon, N. (2011) · Drugs · doi:10.2165/11598070-000000000-00000 · Cited by 204
Surks, M. I., & Ocampo, E. L. (1996) · The American Journal of Medicine · doi:10.1016/s0002-9343(97)89462-4 · Cited by 192
Col, N. F., Surks, M. I., & Daniels, G. H. (2004) · JAMA · doi:10.1001/jama.291.2.239 · Cited by 192
Vadiveloo, T., Donnan, P. T., Cochrane, L., & Leese, G. P. (2011) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2010-2693 · Cited by 186
Sgarbi, J. A., Villaça, F. G., Garbeline, B., Villar, H. E., & Romaldini, J. H. (2003) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2002-021046 · Cited by 177
A 64-Year-Old Woman With a Thyroid Nodule
Mandel, S. J. (2004) · JAMA · doi:10.1001/jama.292.21.2632 · Cited by 166
Wesche, M. F. T., Buul, M. M. C. T.-V., Lips, P. T. A. M., Smits, N. J., & Wiersinga, W. M. (2001) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jcem.86.3.7244 · Cited by 166
Thyroxine Suppressive Therapy in Patients with Nodular Thyroid Disease
Gharib, H., & Mazzaferri, E. L. (1998) · Annals of Internal Medicine · doi:10.7326/0003-4819-128-5-199803010-00008 · Cited by 162
Faber, Jensen, Petersen, Nygaard, Hegedüs, & Siersbæk‐Nielsen (1998) · Clinical Endocrinology · doi:10.1046/j.1365-2265.1998.00427.x · Cited by 156
Gogakos, A. I., Bassett, J. H. D., & Williams, G. R. (2010) · Archives of Biochemistry and Biophysics · doi:10.1016/j.abb.2010.06.021 · Cited by 156
Castro, M. R., Caraballo, P. J., & Morris, J. C. (2002) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2001-011762 · Cited by 150
Moalem, J., Suh, I., & Duh, Q. (2008) · World Journal of Surgery · doi:10.1007/s00268-008-9477-0 · Cited by 146
Biondi, B., Fazio, S., Cuocolo, A., Sabatini, D., Nicolai, E., Lombardi, G., Salvatore, M., & Saccà, L. (1996) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jcem.81.12.8954019 · Cited by 142
The skeletal consequences of thyrotoxicosis
Nicholls, J. J., Brassill, M. J., Williams, G. R., & Bassett, J. H. D. (2012) · Journal of Endocrinology · doi:10.1530/joe-12-0059 · Cited by 138
SERUM THYROID-STIMULATING HORMONE MEASUREMENT FOR ASSESSMENT OF THYROID FUNCTION AND DISEASE
Ross, D. S. (2001) · Endocrinology and Metabolism Clinics of North America · doi:10.1016/s0889-8529(05)70186-9 · Cited by 141
Effect of long-term continuous methimazole treatment of hyperthyroidism: comparison with radioiodine
Azizi, F., Ataie, L., Hedayati, M., Mehrabi, Y., & Sheikholeslami, F. H. (2005) · European Journal of Endocrinology · doi:10.1530/eje.1.01904 · Cited by 139
Subclinical Thyroid Dysfunction and Incident Hip Fracture in Older Adults
Lee, J. S., Bůžková, P., Fink, H. A., Vu, J., Carbone, L., Chen, Z., Cauley, J., Bauer, D. C., Cappola, A. R., & Robbins, J. (2010) · Archives of Internal Medicine · doi:10.1001/archinternmed.2010.424 · Cited by 134
Heemstra, K. A., Hamdy, N. A. T., Romijn, J. A., & Smit, J. W. A. (2006) · Thyroid · doi:10.1089/thy.2006.16.583 · Cited by 134
Wémeau, J.-L., Caron, P. J., Schvartz, C., Schlienger, J.-L., Orgiazzi, J., Cousty, C., & Vlaeminck‐Guillem, V. (2002) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2002-020365 · Cited by 133
Wilson, S., Parle, J., Roberts, L. M., Roalfe, A. K., Hobbs, R. F., Clark, P. M. S., Sheppard, M. C., GAMMAGE, M. D., Pattison, H. M., Franklyn, J. A., et al. (2006) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2006-1557 · Cited by 129
Subclinical Thyroid Disease in the Elderly
Samuels, M. H. (1998) · Thyroid · doi:10.1089/thy.1998.8.803 · Cited by 129
Hypothyroidism in the Elderly: Pathophysiology, Diagnosis and Treatment
Laurberg, P., Andersen, S., Pedersen, I. B., & Carl, A. B. (2005) · Drugs & Aging · doi:10.2165/00002512-200522010-00002 · Cited by 142
Bennedbæk, F. N., Nielsen, L. K., & Hegedűs, L. D. (1998) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jcem.83.3.4673 · Cited by 128
Management of the nontoxic multinodular goitre: A European questionnaire study
Bonnema, S. J., Bennedbæk, F. N., Wiersinga, W. M., & Hegedűs, L. D. (2000) · Clinical Endocrinology · doi:10.1046/j.1365-2265.2000.01060.x · Cited by 115
Fortnightly review: Hypothyroidism: screening and subclinical disease
Weetman, A. (1997) · BMJ · doi:10.1136/bmj.314.7088.1175 · Cited by 128
Adverse Effects of Thyroid Hormone Preparations and Antithyroid Drugs
Bartalena, L., Bogazzi, F., & Martino, E. (1996) · Drug Safety · doi:10.2165/00002018-199615010-00004 · Cited by 108
Subclinical Thyroid Dysfunction
Woeber, K. A. (1997) · Archives of Internal Medicine · doi:10.1001/archinte.1997.00440310023002 · Cited by 107
Thyroid nodules - Stepwise diagnosis and management
Pοlyzos, S. A., Kita, M. D., & Avramidis, A. (2007) · HORMONES · doi:10.14310/horm.2002.111107 · Cited by 106
Population screening for autoimmune thyroid disease.
Tunbridge, W. M., & Vanderpump, M. (2000) · Endocrinology and metabolism clinics of North America (Print) · doi:10.1016/s0889-8529(05)70129-8 · Cited by 101
Monzani, A., Prodam, F., Rapa, A., Moia, S., Agarla, V., Bellone, S., & Bona, G. (2012) · European Journal of Endocrinology · doi:10.1530/eje-12-0656 · Cited by 101
Kung, A. W. C., & Yeung, S. S. (1996) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jcem.81.3.8772604 · Cited by 100
Low Thyrotropin Levels Are Not Associated with Bone Loss in Older Women: A Prospective Study
Bauer, D. C., Nevitt, M. C., Ettinger, B. B., & Stone, K. L. (1997) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jcem.82.9.4229 · Cited by 99
N‐terminal‐pro‐B‐type natriuretic peptide (NT‐pro‐BNP) in different thyroid function states
Schultz, M., Faber, J. O., Kistorp, C., Jarløv, A. E., Pedersen, F., Wiinberg, N., & Hildebrandt, P. R. (2003) · Clinical Endocrinology · doi:10.1111/j.1365-2265.2004.01941.x · Cited by 99
Self-citationMiller, K. K., & Klibanski, A. (1999) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jcem.84.6.5688 · Cited by 97
Osteoporosis in Children and Adolescents
Baroncelli, G. I., Bertelloni, S., Sodini, F., & Saggese, G. (2005) · Pediatric Drugs · doi:10.2165/00148581-200507050-00003 · Cited by 93
Nonsurgical approaches to the management of thyroid nodules
Filetti, S., Durante, C., & Torlontano, M. (2006) · Nature Clinical Practice Endocrinology & Metabolism · doi:10.1038/ncpendmet0215 · Cited by 93
Subclinical Thyroid Dysfunction and the Risk for Fractures: A Systematic Review and Meta-analysis
Wirth, C. D., Blum, M. R., da Costa, B. R., Baumgartner, C., Collet, T.-H., Medici, M., Peeters, R. P., Aujesky, D., Bauer, D. C., & Rodondi, N. (2014) · Annals of Internal Medicine · doi:10.7326/m14-0125 · Cited by 85
Thyroid dysfunction in the elderly
Boelaert, K. (2013) · Nature Reviews Endocrinology · doi:10.1038/nrendo.2013.30 · Cited by 84
Reverter, J. L., Holgado, S., Alonso, N., Salinas, I., Granada, M. L., & Sanmartı́, A. (2005) · Endocrine Related Cancer · doi:10.1677/erc.1.01072 · Cited by 82
Thyroid Hormone Suppression Therapy
Biondi, B., & Cooper, D. S. (2019) · Endocrinology and Metabolism Clinics of North America · doi:10.1016/j.ecl.2018.10.008 · Cited by 81
Fracture Risk in Patients Treated for Hyperthyroidism
Vestergaard, P., Rejnmark, L., Weeke, J., & Mosekilde, L. (2000) · Thyroid · doi:10.1089/thy.2000.10.341 · Cited by 80
Metabolic and Clinical Consequences of Hyperthyroidism on Bone Density
Gorka, J., Taylor‐Gjevre, R. M., & Arnason, T. (2013) · International Journal of Endocrinology · doi:10.1155/2013/638727 · Cited by 83
Relationship between Subclinical Thyroid Dysfunction and Femoral Neck Bone Mineral Density in Women
Lee, W., Oh, K. W., Rhee, E., Jung, C., Kim, S. W., Yun, E. J., Tae, H. J., Baek, K. H., Kang, M. I., Choi, M. G., et al. (2006) · Archives of Medical Research · doi:10.1016/j.arcmed.2005.09.009 · Cited by 78
Thyroid diseases in the elderly
Chiovato, L., Mariotti, S., & Pinchera, A. (1997) · Baillière s Clinical Endocrinology and Metabolism · doi:10.1016/s0950-351x(97)80272-8 · Cited by 77
Thyroid and Aging or the Aging Thyroid? An Evidence-Based Analysis of the Literature
Aggarwal, N., & Razvi, S. (2013) · Journal of Thyroid Research · doi:10.1155/2013/481287 · Cited by 80
Quan, M. L., Pasieka, J. L., & Rorstad, O. P. (2001) · Journal of Surgical Oncology · doi:10.1002/jso.10043 · Cited by 75
Andersen, M. N., Olsen, A. S., Madsen, J. C., Faber, J. O., Torp-Pedersen, C. T., Gislason, G., & Selmer, C. (2015) · PLoS ONE · doi:10.1371/journal.pone.0129793 · Cited by 76
Self-citationMarqusee, E., Haden, S. T., & Utiger, R. D. (1998) · Endocrinology and Metabolism Clinics of North America · doi:10.1016/s0889-8529(05)70296-6 · Cited by 74
Subclinical hypothyroidism in children: natural history and when to treat
Bona, G., Prodam, F., & Monzani, A. (2012) · Journal of Clinical Research in Pediatric Endocrinology · doi:10.4274/jcrpe.851 · Cited by 72
GÜRLEK, A., & GEDIK, O. (1999) · Thyroid · doi:10.1089/thy.1999.9.539 · Cited by 72
Toivonen, J., Tähtelä, R., Laitinen, K., Risteli, J., & Välimäki, M. (1998) · European Journal of Endocrinology · doi:10.1530/eje.0.1380667 · Cited by 71
Thyroid Hormones: Beneficial or Deleterious for Bone?
Lakatos, P. L. (2003) · Calcified Tissue International · doi:10.1007/s00223-002-0027-8 · Cited by 70
Subclinical Hypothyroidism and Cardiovascular Risk
Palmieri, E. A., Fazio, S., Lombardi, G., & Biondi, B. (2004) · Treatments in Endocrinology · doi:10.2165/00024677-200403040-00005 · Cited by 68
Actions of thyroid hormones in bone.
Williams, G. R. (2009) · PubMed · Cited by 66
Is Routine Thyroxine Treatment to Hinder Postoperative Recurrence of Nontoxic Goiter Justified?
Hegedűs, L. D., Nygaard, B., & Hansen, J. (1999) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jcem.84.2.5478 · Cited by 81
THYROID CANCER IN CHILDREN, PREGNANT WOMEN, AND PATIENTS WITH GRAVES' DISEASE
McClellan, D. R., & Francis, G. L. (1996) · Endocrinology and Metabolism Clinics of North America · doi:10.1016/s0889-8529(05)70311-x · Cited by 66
Medici, B. B., Nygaard, B., la Cour, J. L., Grand, M. K., Siersma, V., Nicolaisdottir, D. R., Lind, B., Olivarius, N. D. F., & Andersen, C. L. (2019) · Thyroid® · doi:10.1089/thy.2018.0539 · Cited by 63
Skeletal Integrity in Men Chronically Treated with Suppressive Doses of L‐Thyroxine
Marcocci, C., Golia, F., Vignali, E., & Pinchera, A. (1997) · Journal of Bone and Mineral Research · doi:10.1359/jbmr.1997.12.1.72 · Cited by 60
Lindsay, R. S., & Toft, A. D. (1997) · The Lancet · doi:10.1016/s0140-6736(97)80050-5 · Cited by 62
Ghianda, S. D., Tonacchera, M., & Vitti, P. (2013) · Climacteric · doi:10.3109/13697137.2013.838554 · Cited by 64
Wexler, J. A., & Sharretts, J. M. (2007) · Endocrinology and Metabolism Clinics of North America · doi:10.1016/j.ecl.2007.04.005 · Cited by 61
Possible Limited Bone Loss with Suppressive Thyroxine Therapy Is Unlikely to Have Clinical Relevance
Müller, C., BAYLEY, T. A., Harrison, J. E., & TSANG, R. (1995) · Thyroid · doi:10.1089/thy.1995.5.81 · Cited by 59
Michaelsson, L. F., Medici, B. B., la Cour, J. L., Selmer, C., Røder, M., Perrild, H., Knudsen, N., Faber, J., & Nygaard, B. (2015) · European Thyroid Journal · doi:10.1159/000437262 · Cited by 57
Self-citationJohner, A. M., Griffith, O. L., WALKER, B. A. M., Wood, L., Piper, H. G., Wilkins, G. E., Baliski, C. R., Jones, S. J. M., & Wiseman, S. M. (2011) · Annals of Surgical Oncology · doi:10.1245/s10434-011-1627-1 · Cited by 58
Ku, E. J., Yoo, W. S., Lee, E. K., Ahn, H. Y., Woo, S. H., Hong, J. H., Chung, H. K., & Park, J.-W. (2021) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/clinem/dgab539 · Cited by 57
Caraccio, N., Goletti, O., Lippolis, P. V., Casolaro, A., Cavina, E., Miccoli, P., & Monzani, F. (1997) · Thyroid · doi:10.1089/thy.1997.7.699 · Cited by 57
Metadata
- Authors
- Faber, J., & Galløe, A. M.
- Affiliations
- Frederiksberg Hospital (DK)
- Corresponding author
- Faber, Jens
- ORCID
- Faber, Jens
- Venue
- European Journal of Endocrinology
- Publisher
- Oxford University Press (OUP)
- Published
- 1994-04
- Volume
- 130
- Issue
- 4
- Pages
- 350-356
- ISSN
- 0804-4643 (ISSN-L)
- 1479-683X
- OpenAlex
- W2159860352
- Cited by
- 377
- References
- 0
- Citations by year
- 2026: 3 · 2025: 2 · 2024: 2 · 2023: 2 · 2022: 2 · 2021: 6 · 2020: 7 · 2019: 6 · 2018: 7 · 2017: 9 · 2016: 8 · 2015: 10 · 2014: 12 · 2013: 10 · 2012: 18
- FWCI
- 13.50
- Type
- journal article
- Language
- en
- Open access
- closed
- Locations
- European Journal of Endocrinology (publishedVersion)
- PubMed (publishedVersion)
- Topics
- Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Thyroid Disorders and Treatments
- Health Sciences › Medicine › Orthopedics and Sports Medicine › Bone health and osteoporosis research
- Health Sciences › Medicine › Surgery › Thyroid and Parathyroid Surgery
- Keywords
- subclinical hyperthyroidism, levothyroxine, bone mass, bone loss, osteoporosis risk, TSH suppression, thyroid hormone replacement, postmenopausal women, premenopausal women, distal forearm, femoral neck, lumbar spine, type II error, power analysis
- MeSH terms
- Adult, Cross-Sectional Studies, Female, Femur, Humans, Hyperthyroidism, Hypothyroidism, Lumbar Vertebrae, Middle Aged, Osteoporosis, Radius, Thyroid Neoplasms, Thyrotropin, Thyroxine, Bone Density, Premenopause, Postmenopause
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review